When a man takes an estrogen blocker, his estrogen levels drop and his testosterone levels typically rise. This hormonal shift triggers a cascade of changes throughout the body, some beneficial and some potentially harmful, depending on the reason for taking the medication and how long it’s used. Men take these drugs for a range of reasons, from treating breast tissue enlargement to boosting low testosterone to managing side effects of steroid use. The effects vary significantly based on the type of blocker, the dose, and the individual.
How Estrogen Blockers Work in Men
Men produce estrogen naturally. A portion of their testosterone is continuously converted into estradiol (the primary form of estrogen) by an enzyme called aromatase. This process happens in fat tissue, the brain, bones, and other organs. Healthy adult men typically have estradiol levels between 14 and 54 pg/mL, and that estrogen plays active roles in bone health, brain function, cardiovascular protection, and sexual function.
There are two main categories of estrogen blockers, and they work differently. Aromatase inhibitors (like anastrozole and letrozole) block the enzyme that converts testosterone into estrogen, reducing the amount of estrogen your body produces. They’re potent, but even at full strength they can’t suppress estradiol completely because men have such high circulating testosterone acting as a precursor. Selective estrogen receptor modulators, or SERMs (like tamoxifen and clomiphene), don’t reduce estrogen production. Instead, they block estrogen from binding to receptors in specific tissues, which also tricks the brain into signaling for more testosterone production.
Testosterone Goes Up
One of the most immediate and noticeable effects is a rise in testosterone. When estrogen drops, the brain’s hormonal feedback loop detects the change and ramps up signals to the testes to produce more testosterone. In studies of men with low testosterone treated with clomiphene (a SERM), about 90% saw their testosterone levels increase, with average levels reaching roughly 22.7 nmol/L after 50 days of daily treatment. That’s a meaningful jump into the normal range for many men who started below it.
This testosterone increase is one reason estrogen blockers are sometimes used as an alternative to testosterone replacement therapy in men with late-onset low testosterone. Unlike injections or gels, estrogen blockers stimulate the body’s own production, which preserves fertility and sperm production rather than shutting it down.
Breast Tissue Reduction
Gynecomastia, the enlargement of breast tissue in men, is one of the most common reasons men are prescribed estrogen blockers. Estrogen drives the growth of this tissue, so blocking it can reverse the process, particularly in cases that haven’t been present for years and hardened into fibrous tissue.
SERMs tend to be more effective here than aromatase inhibitors. Tamoxifen produces significant breast tissue reduction in 74% to 95% of patients, with 41% to 78% seeing at least a 50% decrease in size. Raloxifene performs even better for size reduction, with 86% to 93% of patients achieving at least 50% shrinkage. Most men notice results after three to four months of treatment. Aromatase inhibitors like anastrozole are less consistent, producing size reduction in 36% to 72% of patients, though some respond within the first month.
Bone Density Can Suffer
This is one of the most significant risks men don’t expect. Estrogen plays a dominant role in regulating the male skeleton. A landmark study in elderly men systematically removed and replaced testosterone and estrogen independently to isolate their effects. The findings were clear: estrogen was the primary hormone controlling bone breakdown in men, while both estrogen and testosterone contributed to building new bone. Without adequate estrogen, bones lose mineral density and become more fragile over time.
For younger men or those using estrogen blockers short-term, this risk is relatively small. But prolonged use, especially with potent aromatase inhibitors, can meaningfully increase the risk of osteoporosis. This is the same reason aromatase inhibitors are sometimes combined carefully with other treatments in adolescent boys: to get the benefits (like delaying growth plate closure to increase adult height) without sacrificing skeletal strength.
Sexual Function: A Complicated Picture
Many men assume that blocking estrogen and raising testosterone will improve their sex drive. Sometimes it does, particularly if high estrogen was the root problem. But the relationship between estrogen and male sexual function is not a simple “less is better” equation.
Research shows that low estradiol in men is directly associated with erectile dysfunction, ejaculatory problems, and decreased libido. In one study, men with the lowest estradiol levels had significantly worse sexual function across the board, and the association was statistically stronger for estradiol than for testosterone. Men with low estradiol were also more vulnerable to sexual side effects from other medications.
The practical takeaway: if an estrogen blocker pushes your estradiol too low, your sexual function may actually worsen rather than improve. The goal is typically to bring estrogen into a balanced range relative to testosterone, not to eliminate it.
Mood and Mental Health Effects
Estrogen influences brain chemistry in men more than most people realize. It interacts with serotonin receptors and other neurotransmitter systems involved in mood regulation. Low estradiol has been linked to depressive symptoms and reduced overall well-being in men. Some men taking estrogen blockers report feeling flat, irritable, or emotionally blunted, particularly at higher doses or with more aggressive suppression.
On the other hand, men who had symptoms from abnormally high estrogen (fatigue, brain fog, emotional volatility) sometimes report feeling sharper and more stable once their levels normalize. The direction of the mood change depends heavily on where your estrogen levels started and where they end up.
Why Men Take Estrogen Blockers
These medications are prescribed across a surprisingly wide range of conditions in men:
- Low testosterone (late-onset hypogonadism): As an alternative to testosterone replacement that preserves fertility.
- Gynecomastia: To shrink or prevent breast tissue growth.
- Male infertility: Particularly in obese men, where excess aromatase activity converts too much testosterone to estrogen. Case studies describe previously infertile men normalizing their hormone axis, sperm production, and fertility with anastrozole treatment.
- Precocious puberty in boys: Aromatase inhibitors delay growth plate closure and prevent premature skeletal maturation.
- Short stature in adolescents: By delaying bone plate closure, these drugs can extend the growth period and increase final adult height.
- Post-steroid recovery: Men coming off anabolic steroids commonly use SERMs and aromatase inhibitors to restart their body’s natural testosterone production.
Risks of Unsupervised Use
Estrogen blockers are widely available through online pharmacies and bodybuilding suppliers, and many men take them without medical oversight. The danger lies in overcorrection. Crashing your estrogen too low produces a distinct set of symptoms: aching joints, dry skin, fatigue, poor sleep, low libido, and mood disturbances. These can mimic the very symptoms of low testosterone that prompted someone to take the drug in the first place, creating a cycle where men increase their dose and make the problem worse.
Long-term unsupervised use compounds the risks. Bone density loss accumulates silently over months and years. Cholesterol profiles can shift unfavorably, since estrogen helps maintain healthy lipid balance in men just as it does in women. And without blood work, there’s no way to know whether your estradiol has landed in a healthy range or dropped to a level that’s actively causing harm.
Periodic blood testing for estradiol, testosterone, and bone markers is essential for anyone using these medications, whether prescribed or self-administered. The target is hormonal balance, not estrogen elimination.